Baltimore sues J&J unit over 'sham' litigation to extend Zytiga patent- STAT

Baltimore sues J&J unit over 'sham' litigation to extend Zytiga patent- STAT

STAT Plus: Baltimore sues a J&J unit over ‘sham’ patent litigation to extend its monopoly on a cancer drug

By ED SILVERMAN

DANIEL HULSHIZER/AP

The city claims Janssen undertook a “ruse” when seeking a patent for its Zytiga drug by failing to disclose certain information to U.S. patent authorities.

READ MORE